Optometrists in Fort Sill, OK Accepting Medicare
8 Optometrists found. Showing 1 - 8
 Kaylee Faith Aguilar, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4301 Wilson St, Fort Sill, OK 73503 Phone: 833-286-3732 |
Jana L Williams, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4301 Mow-way Road, Rach, Attn: Mcua-qc, Ms. Prescott, Fort Sill, OK 73503 Phone: 580-458-2134 Fax: 580-458-2314 |
Dr. Cassie Lynn Brown, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 4301 Wilson St, Attn: Ruby Prescott, Fort Sill, OK 73503 Phone: 580-558-2134 Fax: 580-558-2314 |
 Dr. Leon Nguyen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2640 Miner Rd, Fort Sill, OK 73503 Phone: 580-585-5600 |
Thu Hua, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4301 Wilson St, Fort Sill, OK 73503 Phone: 408-772-0114 |
Dr. Sherah Vogen, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4301 Wilson St, Fort Sill, OK 73503 Phone: 580-558-8406 Fax: 623-932-7847 |
Jennifer Eng, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2640 Miner Rd, Fort Sill, OK 73503 Phone: 580-585-5600 |
Joshua Falk Optometrist Medicare: Medicare Enrolled Practice Location: 4301 Wilson St, Fort Sill, OK 73503 Phone: 580-558-2947 |
News Archive
Abortion, contraception politics still on front burner as primaries loom
The political furor around abortion and contraception shows no sign of abating, according to news outlets.
On-time surgical starts increase patient and staff satisfaction, reduce costs
Late starts to the first surgical case of the day can be improved, according to two studies presented at the ANESTHESIOLOGY 2013 annual meeting. Improving efficiency potentially reduces costs, increases patient and staff satisfaction, and increases the number of cases that can be performed daily.
Molina Healthcare prices common stock public offering at $27.00 per share
Molina Healthcare, Inc. announced today the pricing of its previously announced underwritten public offering of 4,000,000 shares of common stock by the Company at a public offering price of $27.00 per share. The Company intends to use the net proceeds from the offering to reduce its borrowings under its $200 million senior secured credit facility, which credit facility had an outstanding balance of $105.0 million as of July 30, 2010.
Boehringer Ingelheim files MAA with EMA for afatinib approval
Today, Boehringer Ingelheim has announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for approval of afatinib, the first irreversible ErbB Family Blocker, as a treatment for patients with EGFR (ErbB1) mutation positive non-small cell lung cancer (NSCLC). Afatinib has demonstrated unprecedented efficacy versus chemotherapy in the Phase III LUX-Lung 3 registration trial, which provides pivotal support for this submission.
Researchers to examine risks and benefits of blood transfusions
Risks associated with blood transfusions are to be scrutinized in a new national project that will inform public policy on the process.
› Verified 1 days ago
Physical Therapists
Optometrists
Occupational Therapists
Chiropractors
Audiologists
Podiatrists
Speech-Language Pathologists